Ranbaxy Laboratories Limited

🇨🇷Costa Rica

Country: 🇨🇷Costa Rica

Ownership: -

Established: 1996-08-30

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Zidovudine 300mg tablets

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 68

Registration Number: NCT00779376

Locations: 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada

Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: 120 mg Pseudoephedrine hydrochloride extended release tablets

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00779831

Locations: 🇨🇦
MDS Pharma Services, Saint-Laurent, Quebec, Canada

Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: metformin hydrochloride liquid 500 mg per 5 mL

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00780013

Locations: 🇨🇦
MDS Pharma Services, Saint-Laurent, Quebec, Canada

Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Pseudoephedrine hydrochloride 120 mg ER tablets

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00779805

Locations: 🇮🇳
Ranbaxy CPU, Gurgaon, Haryana, India

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Zidovudine tablets 300 mg

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00779233

Locations: 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: sertraline 100 mg tablets

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00779350

Locations: 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Zolpidem 10mg tablets

First Posted Date: 2008-10-24

Last Posted Date: 2008-10-24

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00779051

Locations: 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States

Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: metformin HC1 750 mg extended-release tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00778141

Locations: 🇺🇸
Gateway medical research, St. Charles, Missouri, United States

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Amoxicillin-Clavulanic acid 600mg - 42.9 mg/ 5 mL oral suspension

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT00778414

Locations: 🇨🇦
Anapharm, Quebec, Canada

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: fluoxetine HCL 40 mg capsules

First Posted Date: 2008-10-23

Last Posted Date: 2009-12-15

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00778024

Locations: 🇺🇸
Gateway medical research, St. Charles, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy